LaserBlood | EIC Pathfinder Project
Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with a survival rate under 10%, largely due to late detection. The LaserBlood project aims to develop a nanoparticle-based blood test for early diagnosis, potentially reducing mortality by up to 80%.